🚀 VC round data is live in beta, check it out!
Intuitive Surgical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Intuitive Surgical and similar public comparables like Thermo Fisher Scientific, Abbott, Siemens, Stryker and more.
Intuitive Surgical Overview
About Intuitive Surgical
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
Founded
1995
HQ
Employees
17.0K
Website
Financials (LTM)
EV
$170B
Intuitive Surgical Financials
Intuitive Surgical reported last 12-month revenue of $10B and EBITDA of $5B.
In the same LTM period, Intuitive Surgical generated $7B in gross profit, $5B in EBITDA, and $3B in net income.
Revenue (LTM)
Intuitive Surgical P&L
In the most recent fiscal year, Intuitive Surgical reported revenue of $10B and EBITDA of $4B.
Intuitive Surgical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $10B | XXX | $10B | XXX | XXX | XXX |
| Gross Profit | $7B | XXX | $7B | XXX | XXX | XXX |
| Gross Margin | 67% | XXX | 66% | XXX | XXX | XXX |
| EBITDA | $5B | XXX | $4B | XXX | XXX | XXX |
| EBITDA Margin | 43% | XXX | 43% | XXX | XXX | XXX |
| EBIT Margin | 37% | XXX | 37% | XXX | XXX | XXX |
| Net Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Net Margin | 32% | XXX | 32% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Intuitive Surgical Stock Performance
Intuitive Surgical has current market cap of $176B, and enterprise value of $170B.
Market Cap Evolution
Intuitive Surgical's stock price is $496.25.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $170B | $176B | 0.0% | XXX | XXX | XXX | $9.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIntuitive Surgical Valuation Multiples
Intuitive Surgical trades at 16.3x EV/Revenue multiple, and 37.8x EV/EBITDA.
EV / Revenue (LTM)
Intuitive Surgical Financial Valuation Multiples
As of April 2, 2026, Intuitive Surgical has market cap of $176B and EV of $170B.
Equity research analysts estimate Intuitive Surgical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Intuitive Surgical has a P/E ratio of 52.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $176B | XXX | $176B | XXX | XXX | XXX |
| EV (current) | $170B | XXX | $170B | XXX | XXX | XXX |
| EV/Revenue | 16.3x | XXX | 16.9x | XXX | XXX | XXX |
| EV/EBITDA | 37.8x | XXX | 39.1x | XXX | XXX | XXX |
| EV/EBIT | 43.7x | XXX | 45.3x | XXX | XXX | XXX |
| EV/Gross Profit | 24.3x | XXX | 25.6x | XXX | XXX | XXX |
| P/E | 52.9x | XXX | 54.4x | XXX | XXX | XXX |
| EV/FCF | 52.3x | XXX | 56.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Intuitive Surgical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Intuitive Surgical Margins & Growth Rates
Intuitive Surgical's revenue in the last 12 month grew by 14%.
Intuitive Surgical's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Intuitive Surgical's rule of 40 is 57% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Intuitive Surgical's rule of X is 79% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Intuitive Surgical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 43% | XXX | 43% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 57% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 79% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 11% | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Intuitive Surgical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Thermo Fisher Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Abbott | XXX | XXX | XXX | XXX | XXX | XXX |
| Siemens | XXX | XXX | XXX | XXX | XXX | XXX |
| Stryker | XXX | XXX | XXX | XXX | XXX | XXX |
| Danaher | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Intuitive Surgical M&A Activity
Intuitive Surgical acquired XXX companies to date.
Last acquisition by Intuitive Surgical was on XXXXXXXX, XXXXX. Intuitive Surgical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Intuitive Surgical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIntuitive Surgical Investment Activity
Intuitive Surgical invested in XXX companies to date.
Intuitive Surgical made its latest investment on XXXXXXXX, XXXXX. Intuitive Surgical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Intuitive Surgical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Intuitive Surgical
| When was Intuitive Surgical founded? | Intuitive Surgical was founded in 1995. |
| Where is Intuitive Surgical headquartered? | Intuitive Surgical is headquartered in United States. |
| How many employees does Intuitive Surgical have? | As of today, Intuitive Surgical has over 17K employees. |
| Who is the CEO of Intuitive Surgical? | Intuitive Surgical's CEO is David J. Rosa. |
| Is Intuitive Surgical publicly listed? | Yes, Intuitive Surgical is a public company listed on Nasdaq. |
| What is the stock symbol of Intuitive Surgical? | Intuitive Surgical trades under ISRG ticker. |
| When did Intuitive Surgical go public? | Intuitive Surgical went public in 2000. |
| Who are competitors of Intuitive Surgical? | Intuitive Surgical main competitors are Thermo Fisher Scientific, Abbott, Siemens, Stryker. |
| What is the current market cap of Intuitive Surgical? | Intuitive Surgical's current market cap is $176B. |
| What is the current revenue of Intuitive Surgical? | Intuitive Surgical's last 12 months revenue is $10B. |
| What is the current revenue growth of Intuitive Surgical? | Intuitive Surgical revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Intuitive Surgical? | Current revenue multiple of Intuitive Surgical is 16.3x. |
| Is Intuitive Surgical profitable? | Yes, Intuitive Surgical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Intuitive Surgical? | Intuitive Surgical's last 12 months EBITDA is $5B. |
| What is Intuitive Surgical's EBITDA margin? | Intuitive Surgical's last 12 months EBITDA margin is 43%. |
| What is the current EV/EBITDA multiple of Intuitive Surgical? | Current EBITDA multiple of Intuitive Surgical is 37.8x. |
| What is the current FCF of Intuitive Surgical? | Intuitive Surgical's last 12 months FCF is $3B. |
| What is Intuitive Surgical's FCF margin? | Intuitive Surgical's last 12 months FCF margin is 31%. |
| What is the current EV/FCF multiple of Intuitive Surgical? | Current FCF multiple of Intuitive Surgical is 52.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.